Minocycline-Induced Hyperpigmentation in a Patient Treated with Erlotinib for Non-Small Cell Lung Adenocarcinoma

Brzezniak C.E; Bell A.T; Roman J.W; Gratrix M.L

首页> 外文期刊>Case Reports in Oncology >Minocycline-Induced Hyperpigmentation in a Patient Treated with Erlotinib for Non-Small Cell Lung Adenocarcinoma

【24h】

Minocycline-Induced Hyperpigmentation in a Patient Treated with Erlotinib for Non-Small Cell Lung Adenocarcinoma

机译：厄洛替尼治疗非小细胞肺癌患者米诺环素诱导的色素沉着过度

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Introduction: While epidermal growth factor receptor (EGFR) inhibitors have improved progression-free survival in patients with non-small cell lung cancer (NSCLC), one of the most common adverse effects is papulopustular skin eruption, which is frequently

机译：简介：虽然表皮生长因子受体（EGFR）抑制剂可改善非小细胞肺癌（NSCLC）患者的无进展生存期，但最常见的不良反应之一是丘疹性皮疹，这种病经常发生

著录项

来源
《Case Reports in Oncology》 |2017年第1期|共页
作者
Brzezniak C.E; Bell A.T; Roman J.W; Gratrix M.L;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类临床医学;
关键词

相似文献

外文文献
中文文献
专利

1. Retrospective Assessment of a Serum Proteomic Test in a Phase III Study Comparing Erlotinib plus Placebo with Erlotinib plus Tivantinib (MARQUEE) in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer [J] . Buttigliero Consuelo, Shepherd Frances A., Barlesi Fabrice, The oncologist . 2019,第6期

机译：在先前治疗的非小细胞肺癌患者中，Erlotinib Plus安慰剂与Erlotinib Plus Tivantinib（Marquee）对血清蛋白质组学试验的回顾性评估
2. Retrospective Assessment of a Serum Proteomic Test in a Phase III Study Comparing Erlotinib plus Placebo with Erlotinib plus Tivantinib (MARQUEE) in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer [J] . Consuelo Buttigliero, Adele R. Blackler, Joanna Roder, The oncologist . 2019,第6期

机译：在先前治疗的非小细胞肺癌患者中，Erlotinib Plus安慰剂与Erlotinib Plus Tivantinib（Marquee）对血清蛋白质组学试验的回顾性评估
3. A Prospective Evaluation of Circulating Tumor Cells and Cell-Free DNA in EGFR-Mutant Non-Small Cell Lung Cancer Patients Treated with Erlotinib on a Phase II Trial [J] . Yanagita Masahiko, Redig Amanda J., Paweletz Cloud P., Clinical cancer research: an official journal of the American Association for Cancer Research . 2016,第24期

机译：厄洛替尼治疗的EGFR突变型非小细胞肺癌患者的II期临床试验中对循环肿瘤细胞和无细胞DNA的前瞻性评估
4. IMPROVING PREDICTION OF SURVIVAL USING CT-BASED TUMOR CHARACTERISTICS IN PATIENTS TREATED FOR METASTATIC NON-SMALL CELL LUNG CANCER [C] . WALKER H. LAND JR., ALAN LITWIN, DAN MARGOLIS, Artificial Neural Networks in Engineering Conference . 2010

机译：基于CT基肿瘤特征改善对转移性非小细胞肺癌的患者的肿瘤特征预测
5. Assessing the effectiveness of palliative chemotherapy for non-small cell lung cancer: A phase IV study of patients treated at Ontario's cancer centres [D] . Harrison, Lyndsay Dawn. 2012

机译：评估姑息化疗对非小细胞肺癌的有效性：在安大略省癌症中心接受治疗的患者的IV期研究
6. Minocycline-Induced Hyperpigmentation in a Patient Treated with Erlotinib for Non-Small Cell Lung Adenocarcinoma [O] . Ann T. Bell, John W. Roman, Max L. Gratrix, 2017

机译：厄洛替尼治疗非小细胞肺癌患者米诺环素诱导的色素沉着过度
7. Minocycline-Induced Hyperpigmentation in a Patient Treated with Erlotinib for Non-Small Cell Lung Adenocarcinoma [O] . Ann T. Bell, John W. Roman, Max L. Gratrix, 2017

机译：厄洛替尼治疗非小细胞肺腺癌患者米诺环素诱导的色素沉着过度

Minocycline-Induced Hyperpigmentation in a Patient Treated with Erlotinib for Non-Small Cell Lung Adenocarcinoma

摘要

著录项

相似文献

相关主题

期刊订阅